Osteoporosis Drug Actonel Helps Prevent Future Fractures

Recently, the U.S. Food and Drug Administration (FDA) approved a new once-a-month dose of Actonel® (risedronate sodium) tablets making it the only oral once-a-month osteoporosis therapy approved to help prevent both spinal and non-spinal fractures in postmenopausal women. The new once-a-month dose of Actonel is available for patients seeking the fracture protection of Actonel in the convenience of one monthly pill. In addition to being approved to help protect the spine from fractures, Actonel is also approved to help prevent non-spinal fractures, measured as a group, namely the hip, wrist, collar bone, arm, pelvis, and leg.

Category:

Science & Technology

Tags:

• Health
• news
• actonel
• osteoporosis
• FDA
• One
• month
• Pharmacutical
• medical
• post
• menopause
• women
• treatment
• fractures
• medicine

[rusmotor]

I just participated in bio-equivalence study with Actonel 150mg. Half the group developed fever of 47.5C to 38 C. ALL experienced some degree of muscle pain.

My temperature was slightly elevated. Some joint pain. Not a pleasant experience at all.

[yvonnahue]

This is a dangerous drug that has not been tested properly. Do Not ingest this drug. Tell the dr who prescribes it to you that you would like to be there when he takes one and you'll watch his reaction over the next week